Gil Blum
Stock Analyst at Needham
(0)
# 4178
Out of 5,240 analysts
375
Total ratings
32.06%
Success rate
-7.38%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Sarepta Therapeutics | Reiterates: Buy | 202 202 | 118.71 | 70.16% | 26 | Jan 14, 2025 | |
CRISPR Therapeutics | Reiterates: Buy | 84 84 | 38.34 | 119.09% | 18 | Jan 14, 2025 | |
Cartesian Therapeuti... | Reiterates: Buy | 41 41 | 18 | 127.78% | 11 | Jan 13, 2025 | |
Autolus Therapeutics | Reiterates: Buy | 10 10 | 2.2 | 354.55% | 26 | Jan 13, 2025 | |
Geron | Maintains: Strong Buy | 6 7 | 2.94 | 138.1% | 20 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 7 7 | 3.06 | 128.76% | 15 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 5 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 71 71 | 28.5 | 149.12% | 11 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 8 | 0.89 | 798.88% | 14 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 6 6 | 1.64 | 265.85% | 24 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 11 11 | 6.31 | 74.33% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 11 11 | 2.62 | 319.85% | 5 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 29 29 | 18.56 | 56.25% | 21 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 105 105 | 64.58 | 62.59% | 23 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 52 52 | 10.45 | 397.61% | 18 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 5 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 23 23 | 10.49 | 119.26% | 12 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 15 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 23 23 | 6.97 | 229.99% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 13 11 | 2.21 | 397.74% | 14 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 18 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 4 4 | 0.79 | 406.33% | 9 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 6 6 | 1.04 | 476.92% | 12 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 6 | n/a | n/a | 8 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 4 | n/a | n/a | 9 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 7 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 72 | n/a | n/a | 4 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jun 3, 2022 |